DISCERN aims to uncover novel causes of renal, pancreatic, and colorectal cancers.
The project will incorporate large-scale cancer biorepositories and novel exposomics techniques to understand the causes of these three poorly understood cancer types in Europe.
It also aims to explain their geographical distribution, including their high incidence in central and eastern Europe.
It will integrate large-scale cancer biorepositories and state-of-the-art exposomics and proteomics techniques, as well as genomics technologies, to compare normal tissue with tumour tissue.
The comparison will unravel novel causes for each of these three cancers to ultimately provide scientific evidence necessary to develop new prevention strategies for these cancers in Europe.
To find out more about the project, please visit the official website of DISCERN